Lei Zheng

Mays Cancer Center at UT San Antonio Health Science Center

National Cancer Institute · P30

Contact PI · $6.6M · University of Texas Hlth Science Center

Transforming Human Pancreatic Cancer Into An Immunologic Disease

National Cancer Institute · P01

Project lead · $1.7M · Johns Hopkins University

Interrogate the Interaction Between Tumor Cells and Nerves in the Tumor Microenvironment of Pancreatic Cancer

National Cancer Institute · R01

Contact PI · $3.6M · University of Texas Hlth Science Center

Targeting the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer with a Neoadjuvant Platform Clinical Trial

National Cancer Institute · R01

Contact PI · $4M · Johns Hopkins University

Resection/Synchronous Pulmonary or Hepatic Oligometastatic Pancreatic Ductal Adenocarcinoma

Principal investigator · Recruiting

The University of Texas Health Science Center at San Antonio

Intermittent Theta Burst Stimulation of the Prefrontal Cortex in Social Anxiety Disorder

Principal investigator · Recruiting

Second Affiliated Hospital, Zhejiang University, School of Medicine

A Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas Cancer

Principal investigator · Active not recruiting · Phase 2

Lei Zheng

Durvalumab and SNDX-6532 Following Chemo or Radio-Embolization for Patients With Intrahepatic Cholangiocarcinoma

Principal investigator · Completed · Phase 2

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins